
Teicoplanin (Zyntex) is a high-potency glycopeptide antibiotic API used for treating serious infections caused by Gram-positive bacteria, including MRSA and Enterococcus faecalis
Maximum compound integrity and strict batch traceability provide a critical competitive advantage for pharmaceutical manufacturing lines developing specialized antibacterial products. This glycopeptide derivative functions by disrupting peptidoglycan polymerization, leading to a stable bactericidal outcome without altering the chemical balance of non-target organic elements. It assists formulation engineers in maintaining precise bio-equivalence across complex industrial medicine groups. For instance, Teicoplanin serves as a premier therapeutic agent when dealing with methicillin-resistant micro-organisms in intensive healthcare environments. Consequently, incorporating this premium chemical agent elevates the baseline quality and standard compliance of your final commercial batch. As a result, Zyntex enforces strict validation testing for every single distribution lot, ensuring ultimate batch continuity.
Moreover, Zyntex coordinates specialized logistics operations required to maintain chemical purity for delicate macrocyclic structures during cross-border transport. This active chemical substance is highly valued in advanced biochemical research, acting as a reliable standard for investigating microbial mutation rates and specific peptide binding mechanisms. It opens new operational paths for testing custom clinical formulations by serving as an exact building block for pharmaceutical development batches. At the same time, it remains an essential reference standard used by internal quality control teams to analyze chemical degradation limits over time. In short, our product functions as a highly dependable antibiotic input, preserving both final formulation performance and technical manufacturing accuracy.
Recently, industrial attention regarding its implementation in advanced slow-release bone cement formulations and complex orthopedic medicine arrays has expanded significantly. It offers a clean and predictable chemical foundation for discovering alternative medical solutions for sensitive biological matrices. Because of this, Zyntex offers refined, low-endotoxin grades specifically created to satisfy the detailed regulatory requirements of modern clinical facilities worldwide. Ultimately, selecting Zyntex guarantees a reliable, fully documented, and robust raw material channel. We successfully blend industry-focused chemical logistics with strict global quality assessments. To conclude, our operational dedication ensures that your industrial processing applications retain the highest possible molecular accuracy and chemical purity.
This high-purity glycopeptide active pharmaceutical ingredient is crucial in these four sectors:
Primary active component for lyophilized infusion powders and parenteral formulations. Thus, it provides high biological performance.
Core raw chemical for producing targeted MRSA treatments and critical hospital drugs. Undoubtedly, it ensures reliable clinical action.
Essential selective agent for advanced laboratory media development. Consequently, it assists in precision isolation operations.
Key reference substance for measuring structural glycopeptide relative potencies. Specifically, it maintains perfect system calibration.
| Parameter | Standard Value |
|---|---|
| Product Name | Teicoplanin |
| Molecular Formula | C88H97Cl2N9O33 (Teicoplanin A2-2) |
| Assay (Potency) | ≥ 900 µg /mg (on anhydrous basis) |
| CAS Number | 61036-62-2 |
📝 Safety & Handling: Teicoplanin can cause mild hypersensitivity and targeted structural reactions upon direct operational inhalation. Therefore, store in tightly sealed containers at a cold temperature (2°C to 8°C) within a dry, moisture-free warehouse. Avoid dust accumulation and use full professional pharmaceutical PPE including protective chemical gloves, filtering facepieces, and safety eyewear. Always review the full Safety Data Sheet (SDS) for local environmental protocols.